Pfizer Inc (NYSE: PFE)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 07/19/2024
Closing price: 29.97
Support price level: | $28.35 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 73.0 |
Beta | 0.56 |
- With a -17.8 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- PFE is one of this month's top performers with a return of 8.0 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- PFE is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, PFE is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$25.26 | $37.51 | 43.2% |
200 day | 50 day | 20 day | 10 day |
$28.50 | $28.41 | $28.45 | $28.99 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
27.1% | 24.5% | 22.8% | 25.6% |
- 6.2% in the next week.
- 14.5% in the next month.
- 48.1% in the next year.
Company news for Pfizer Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks